Adenoid basal carcinoma of the uterine cervix is rare and its cell origin is still obscure. We report a case of adenoid basal carcinoma of the uterine cervix discovered incidentally in a 69-year-old woman who had been hysterectomized due to endometrial adenocarcinoma of the uterine corpus. Histologically, small round-to-oval cancer cell nests with peripheral cell palisading were seen budding from the basal cell layer of the uterine cervix showing carcinoma in situ. Immunohistochemically, the basaloid cells of the adenoid basal carcinoma were positive for keratins 14, 17 and 19 and resembled reserve cells of the cervical epithelium. The results of this study clearly demonstrated that adenoid basal carcinoma shows a phenotype similar to reserve cells of the uterine cervix. A review of the literature indicated that this tumor has a favorable prognosis and should be clearly separated from adenoid cystic carcinoma, which has a much poorer outcome.
INTRODUCTION
Adenoid basal carcinoma of the uterine cervix, first distinguished from adenoid cystic carcinoma by Baggish and Woodruff in 1966 (1), accounts for less than 1% of all cervical adenocarcinomas (2) (3) (4) . A search of the English literature since the first description reveals only 33 cases (1) (2) (3) (5) (6) (7) (8) (9) . Adenoid basal carcinoma is thought to be derived from the multipotential basal or reserve cell layer of the cervical epithelium (1, 5, 7) , but this has not been confirmed. Clinically, the prognosis is usually favorable; therefore, this carcinoma must be distinguished from the more aggressive adenoid cystic carcinoma of the uterine cervix (2-4), which is sometimes very similar histologically. Here we report a case of adenoid basal carcinoma of the cervix discovered incidentally in a patient with endometrial adenocarcinoma of the uterine corpus. The clinical, histological and immunohisto-
CASE REPORT
The patient was a 69-year-old Japanese woman who presented with a 2 month history of abnormal genital bleeding. She had borne three children and her last menstrual period had been 15 years earlier. Her medical history included an aorta-coronary bypass graft 2 years earlier. No gross lesion was noted on the cervix and the cervicovaginal smear cytology was reported to be Class II. Ultrasonography showed a polypoid mass within the uterine corpus, which was diagnosed histologically as endometrial adenocarcinoma from a curettage specimen. This was thought to be the likely cause of the genital bleeding. The pelvic adnexal structures were normal. The serum level of the tumor marker carbohydrate antigen 125 (CA125) was elevated (115 U/ml; normal <35 U/ml), whereas the serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9, α-fetoprotein, squamous cell carcinoma antigen and sialyl Lewis X were within the normal ranges. No further relevant features were found on general examination. Therefore, she was considered to have carcinoma of the uterine corpus, early stage I, and a total hysterectomy and bilateral salpingo-oophorectomy with bilateral pelvic lymphadenectomy was performed. The patient is being closely followed up and has shown no evidence of recurrence within 6 months after the operation. Macroscopically, a small polypoid tumor was identified at the uterine corpus (arrowhead), whereas the cervix appeared normal (Fig. 1) . Histologically, the tumor at the corpus was a well differentiated endometrial adenocarcinoma in which the depth of invasion was limited to within the endometrium, and this was considered to be stage Ia according to the FIGO staging system.
Histological examinations of specimens from the surface epithelium of the uterine cervix showed carcinoma in situ (CIS) with glandular involvement (Fig. 2) . Deep in the stroma beneath, small round-to-oval cancer cell nests, sometimes budding from the basal layer of the CIS, resembling those of basal cell carcinoma or basosquamous cell carcinoma of the skin, were evident; peripheral cell palisading was also found (Fig. 3) . The tumor cells were small and uniform, with dark oval nuclei without conspicuous nucleoli and scanty cytoplasm. Mitotic activity was low. The central portions of the tumor cell nests formed cystic spaces filled with necrotic debris or eosinophilic material or occasionally showed squamous differentiation. Among the majority of PAS-negative cystic spaces forming false lumina, columnar cells surrounding PAS-positive secretory material forming true lumina were rarely seen (Fig. 3) . No stromal reaction was evident. Neither lymphatic nor vascular invasion was identified and no metastasis was seen in sections taken from 18 excised lymph nodes. The cervical lesion was diagnosed as adenoid basal carcinoma and was at stage Ib.
Immunohistochemistry was performed using a labeled streptavidin-biotin staining kit (Dako, Carpinteria, CA, USA) according to the manufacturer's instructions. The polyclonal antisera and monoclonal antibodies used and their sources are listed in Table 1 . For demonstration of keratins, estrogen receptor (ER), progesterone receptor (PgR), proliferating cell nuclear antigen (PCNA) and p53, antigen retrieval by microwave oven heating was essential (10). For negative controls, serial sections were incubated with non-immune serum at a comparable dilution. In addition, the ubiquity of the normal epithelium of the ecto-and endocervix served as a built-in positive control for keratin immunohistochemistry.
In this adenoid basal carcinoma, although mitoses were rare, PCNA labeled the majority of tumor cell nuclei, while stromal cells were almost always negative. In contrast, the stromal cells were consistently positive for ER and PgR, while the tumor cells were invariably negative. All tumor cells including the peripheral palisading cells were negative for S-100 protein and actin, suggesting no myoepithelial differentiation. The palisading basaloid cells at the periphery expressed keratins 7, 8, 14, 17 (Fig.  4) , 18 and 19 and the foci of squamous differentiation expressed keratins 10 and 13. The cells surrounding true lumina were positive for keratins 7, 8, 18 (Fig. 4) and 19 and CEA. p53 staining of tumor cell nuclei was very rarely seen and CA125 staining was completely negative. 
DISCUSSION
Adenoid basal carcinoma of the uterine cervix is an uncommon lesion for which the cell origin is still controversial. In the human female genital tract, the expression of various keratin polypeptides in normal and pathological specimens has been examined (11) (12) (13) (14) . In the present case, the basaloid cells expressed keratins 14, 17 and 19. In particular, the expression of keratin 17 resembled that of reserve cells of the cervical epithelium. In addition, the expression of keratins 10 and 13 in foci of squamous differentiation and of keratins 7, 8, 18 and 19 in cells surrounding a few lumina suggests that adenoid basal carcinoma shows distinct squamous and glandular differentiation. The 34 cases of adenoid basal cell carcinoma (including the present case) reported previously in the English literature (1-3,5-9) are summarized in Table 2 . Clinically, these adenoid basal carcinomas occurred almost exclusively in post-menopausal women, with a mean age of 63 years (36-80 years). The patients were usually asymptomatic (68%) and had come to medical attention after an abnormal cervical smear result. Symptoms, if present, included genital bleeding, cervical prolapse and abdominal mass. Grossly, most of the cervixes appeared normal (69%) and usually no gross mass was present. In most of the reported cases, adenoid basal carcinoma was associated with cervical intraepithelial neoplasia (CIN) (89%). In the present case, adenoid basal carcinoma was associated with CIN and endometrial adenocarcinoma and a review of the English literature failed to find a similar case. Generally, the clinical outcome is favorable, but distant metastasis was reported in one case.
Histologically, adenoid basal carcinoma is frequently confused with adenoid cystic carcinoma, which is also a rare neoplasm arising in the uterine cervix (2) (3) (4) . The distinction between adenoid basal cell carcinoma and adenoid cystic carcinoma is summarized in Table 3 . Grossly, adenoid cystic carcinoma frequently forms an irregular polypoid mass, whereas adenoid basal carcinoma usually does not form a gross mass. Histologically, adenoid basal carcinoma is characterized by less pleomorphic nuclei and less mitotic activity (2) (3) (4) (5) . Although mitosis was rare, a considerable amount of PCNA labeling, indicative of a high cell turnover, was seen in the present case. Formation of true lumina with microvilli is characteristic of adenoid cystic carcinoma (15) . However, in the present case, true lumina were seen and these were surrounded by cells exhibiting a glandular phenotype, as demonstrated by keratin expression. Both adenoid basal carcinoma and adenoid cystic carcinoma show squamous differentiation within the cancer cell nests. Therefore, the existence of true lumina or squamous differentiation cannot be used to differentiate these two neoplasms. In adenoid cystic carcinoma, necrosis is common (4, 16) and hyalinization is seen in the stroma (3, (15) (16) (17) (18) , whereas adenoid basal carcinoma does not show such changes. Lymphatic invasion is seen in adenoid cystic carcinoma (15, (17) (18) (19) but not in adenoid basal carcinoma. CIN is associated in both cancers, but more frequently in adenoid basal carcinoma (3). (6) The differential diagnosis of these two cancers is essential because the clinical outcome is markedly different (Table 3) . Adenoid cystic carcinoma behaves aggressively, i.e. lymphatic invasion is common and local recurrence or metastatic spread is frequent, and about half of the reported patients died of the tumor or had local recurrence along with distant metastasis to the lungs, liver, bone or other sites (2, 3, (16) (17) (18) . Since the prognosis of adenoid basal carcinoma is favorable, radical surgery is recommended. However, if the tumor is associated with adenocarcinoma or squamous cell carcinoma, the treatment will depend on the stage of these carcinomas (2). Since we found no hormone receptors (ER, PgR) in the present adenoid basal carcinoma, hormone therapy was not a treatment choice.
In conclusion, the reserve cells of the cervical epithelium and the basaloid cells of adenoid basal cell carcinoma are positive for keratins 14, 17 and 19, which share a similar keratin phenotype; however, glandular and squamous differentiation is also present. The tumor cells do not contain ER or PgR.
